SCNX — Scienture Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1382574 ·
Last close
$2.76
Market Cap
$113.34M
52W High
$18.75
52W Low
$2.64
ADV30
47,928
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,254,577 | 1,019,949 | -5,723,506 | -6,009,447 | 87,184,306 | 4,747,439 | 28,440,722 |
| Jun 2026 | 343,639 | 335,779 | -2,699,733 | -2,822,371 | 87,734,007 | 8,188,140 | 23,632,481 |
| Mar 2026 | 56,325 | 53,850 | -3,509,499 | -3,402,264 | 80,661,705 | 3,542,754 | 13,841,265 |
| Dec 2025 | -168,699 | -243,812 | -3,154,363 | -28,120,333 | 84,178,330 | 6,662,008 | 14,057,946 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,443,375
Investing CF
$0
Financing CF
$25,625,596
CapEx
—
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.82
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-86,775,872
Inventory
$203,074
Receivables
$385,313
ST Investments
—
EBIT TTM
$-36,881,474
Pretax Income TTM
$-39,947,207
Interest Exp TTM
$3,065,733
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$821,315
EBITDA
$-12,361,262
Free Cash Flow
$-7,611,433
Enterprise Value
$16,787,558
Total Cash
$8,188,140
Total Debt
$10,689,481
Shares Out
41,064,146
Trailing EPS
$-2.03
Book Value
$1.56
ROE
-53.5%
ROA
-8.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 431,609 | -16,244,792 | -41,512,264 | 84,178,330 | 14,057,946 | 70,120,384 | -13,379,683 |
| Dec 2024 | 136,643 | -14,701,015 | 9,065,798 | 104,853,805 | 25,781,684 | 79,072,121 | -14,265,238 |
| Dec 2023 | 1,363,830 | -4,396,451 | -17,843,574 | 12,532,913 | 11,990,560 | 542,353 | -2,225,192 |
| Dec 2022 | 10,250,168 | -2,040,719 | -3,472,099 | 3,710,026 | 3,367,159 | 763,136 | -1,564,668 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$821,315
NetIncome TTM
$-37,952,329
OpCashFlow TTM
—
Assets (Latest)
$87,734,007
Forward EPS
$0.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UPB | Upstream Bio, Inc. | $115.10M | $2.10 | — |
| AKBA | Akebia Therapeutics, Inc. | $111.18M | $0.40 | — |
| SPRB | SPRUCE BIOSCIENCES, INC. | $116.37M | $40.49 | — |
| FHTX | Foghorn Therapeutics Inc. | $109.73M | $1.83 | — |
| NRXP | NRX Pharmaceuticals, Inc. | $106.07M | $2.45 | — |
News headlines (Yahoo Finance, 1h cache)
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
2026-11-16 13:30 · Yahoo
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
2026-10-22 12:05 · Yahoo
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
2026-10-13 12:05 · Yahoo
EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
2026-10-13 11:45 · Yahoo
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
2026-10-02 12:05 · Yahoo
EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
2026-10-02 11:46 · Yahoo
Scienture Holdings, Inc. Announces Reverse Stock Split
2026-09-30 20:05 · Yahoo
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
2026-09-22 12:15 · Yahoo
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
2026-06-18 12:05 · Yahoo
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
2026-06-02 12:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.